Weight-loss drugs called GLP-1s are revolutionizing obesity treatment, with new developments including more effective medications, lower prices, and upcoming oral versions, though access remains limited due to high costs and insurance restrictions.
The nationwide shortage of ADHD drugs, particularly Adderall, has led to significant price increases for patients seeking medication to manage their symptoms. Families are being forced to pay more for expensive brand-name drugs as alternatives, putting financial strain on households. The shortage has disrupted the lives of millions of individuals with ADHD, impacting their performance at school and work. The increased demand for ADHD drugs, combined with regulatory constraints on production, has created a challenging situation for patients and healthcare providers. Efforts are being made to address the shortage, but it may take time for the supply to stabilize.